Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FP.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.571EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.55 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.239EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.574EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.355EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.403EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.66EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.21.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ES.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.479EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.437EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.371EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.625EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.507EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.178EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.273EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.211EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.474EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.297EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used